NMPA

SINGAPORE and NORTH BRUNSWICK, N.J., Aug. 3, 2026 Adlai Nortye Ltd. has advanced its oncology pipeline after submitting a...

SHANGHAI, China & NEW YORK, July 20, 2026 Argo Biopharma has announced the successful dosing of the first participant...

SHANGHAI and HONG KONG, China, July 13, 2026 Antengene has announced the receipt of a USD 60 million upfront...

SHANGHAI, China, July 10, 2026 Hansoh Pharmaceutical Group Co., Ltd. has announced that its Phase III ARTEMIS-008 clinical trial...

NANJING, China | July 10, 2026 Nanjing Leads Biolabs Co., Ltd. has announced that the Center for Drug Evaluation...

NANJING, China, July 9, 2026 InxMed Co., Ltd., a clinical-stage biotechnology company focused on overcoming cancer treatment resistance, has...

SOUTH SAN FRANCISCO, Calif., July 6, 2026 Aligos Therapeutics has received a $25 million upfront payment from Xiamen Amoytop...

DURHAM, North Carolina & BEIJING, China, July 3, 2026 Brii Biosciences Limited (Brii Bio) has announced positive topline end-of-treatment...

Shanghai, China, July 1, 2026 Junshi Biosciences has entered into a landmark licensing collaboration with Fosun Wanbang Pharma Group,...

Hong Kong, Shanghai & Florham Park, N.J., July 2, 2026 HUTCHMED has achieved a major regulatory milestone after the...